The development of all treatments, including vaccines, is dependent on people taking part in clinical trials but this can be ...

A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...

GSK’s fully liquid presentation of its meningococcal vaccine Menveo has been approved by the European Commission (EC) to ...

Galderma’s nemolizumab has been shown to improve the core signs and symptoms of prurigo nodularis, according to phase 3 ...

Health equity, a fundamental human right, remains elusive for many. As health communicators, we play a crucial role in addressing these disparities, bridging gaps and supporting underserved ...

The US Food and Drug Administration (FDA) has approved BridgeBio Pharma’s Attruby (acoramidis) to treat adults with ...

Novartis and Ratio Therapeutics have entered into a worldwide licence and collaboration agreement worth $745m to advance a ...

Live meetings have come a long way in recent years, but let’s face it – ‘passive listening’ is a concept best left in the ...

UCB’s Bimzelx (bimekizumab-bkzx) has been approved by the US Food and Drug Administration (FDA) to treat active ...

Don’t be simplistic with your complex problems ...

The medical communications (med comms) industry is critical in bridging the gap between new medical innovations, healthcare ...

Medscape will showcase eight educational symposia and three posters at ASH 2024, highlighting advancements in hematology and ...